Simulations Plus (SLP) has released an update.
Simulations Plus, Inc., a leading software company in the pharmaceutical research sector, is set to present at the Oppenheimer investor conference on February 13, 2024. Investors can access the presentation on the company’s website, offering insights into the company’s future. However, the company cautions that any forward-looking statements included in the presentation carry risks and uncertainties, and actual results could vary from those projected.
For further insights into SLP stock, check out TipRanks’ Stock Analysis page.
